3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polycystic Ovary Syndrome
13
Obesity
6
Weight Loss
5
Overweight
3
Menstruation Disturbances
2
Intermittent Fasting
2
Insulin Resistance
2
Tumor Surgery
1
Sarcopenia
1
Postoperative Complications
1
Obesity, Abdominal
1
Muscle Weakness
1
Motor Activity
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Infertility
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Breast Cancer Female
1
Body Weight
1
Interventions
Creatine
2
telitacicept
1
nicotinamide-beta-riboside
1
fludarabine
1
Testosterone
1
Positron-Emission Tomography
1
Magnetic Resonance Imaging
1
Exercise Movement Techniques
1
Eicosapentaenoic Acid
1
Cyclophosphamide
1
Carnitine
1
Caloric Restriction
1
Autogenic Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Muscle Weakness
×
Caloric Restriction
×
Clear all
NCT03676478
2025-12-10
EFECTS
University Hospital, Gasthuisberg
Phase NA
Terminated
239 enrolled